Analyst picks & changes

Amylin Pharmaceuticals Inc.

(AMLN), San Diego, Calif.

Business: Metabolic

Vector Securities International analyst Michael King said he was encouraged by results of AMLN's first two Phase

Read the full 265 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE